In non-st-elevation acute coronary syndrome, coronary thrombus formation is not associated with electrocardiographic changes

dc.contributor.authorYener, Ali Ümit
dc.contributor.authorÖzkan, Muhammed Turgut Alper
dc.contributor.authorÇiçek, Mustafa Cüneyt
dc.contributor.authorTemIz, Ahmet
dc.date.accessioned2025-01-27T19:06:08Z
dc.date.available2025-01-27T19:06:08Z
dc.date.issued2014
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractAntiplatelet agents are important drugs that are used in the treatment of coronary artery disease (CAD). Antiplatelet therapy especially after an acute coronary syndrome (ACS) is crucial. However, approximately 5% of patients who receive coronary stents are expected to require cardiac or non-cardiac surgery within 1 year after percutaneous coronary intervention (PCI). In this review we discuss the scenarios that can reduce the risk of these patients. It is ideal that non-urgent surgery should be delayed for the time to discontinue antiplatelet therapy confidently. The best approach involves the interdisciplinary teamwork with surgeon, cardiologist, anesthetist and patient which review all the related situations.
dc.identifier.endpage48
dc.identifier.issn1307-1173
dc.identifier.issue1
dc.identifier.scopus2-s2.0-84893699837
dc.identifier.scopusqualityN/A
dc.identifier.startpage46
dc.identifier.urihttps://hdl.handle.net/20.500.12428/14158
dc.identifier.volume8
dc.indekslendigikaynakScopus
dc.language.isoen
dc.relation.ispartofAnatolian Journal of Clinical Investigation
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20250125
dc.subjectAntiplatelet therapy; Aspirin; Bleeding; Clopidogrel; Surgery
dc.titleIn non-st-elevation acute coronary syndrome, coronary thrombus formation is not associated with electrocardiographic changes
dc.title.alternativeperi?operati?f dönemde anti?platelet tedavi? alan hastalarda kanama kaçinilmaz midir?
dc.typeReview Article

Dosyalar